2016-2020 US Molecular Diagnostics Market: Supplier Shares by Test, Volume and Sales Forecasts by Application

March 2016 | 42 pages | ID: 2909D407592EN
Venture Planning Group

Abstracts

This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test. Contains 42 pages and 5 tables

Contents

1. HEALTH CARE EXPENDITURES

2. COST CONSCIOUSNESS

3. REIMBURSEMENT

4. INDUSTRY CONSOLIDATION

5. MANAGED CARE

a. PPO
b. HMO

6. HOSPITALS

7. ADMISSIONS

8. LENGTH OF STAY

9. INDUSTRY DIVERSIFICATION

10. PHYSICIAN DEMOGRAPHICS

11. POPULATION AGING

a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases

12. LABORATORY REGULATIONS

13. FDA REFORM

MARKET STRUCTURE

1. HOSPITALS
2. COMMERCIAL/PRIVATE LABORATORIES
3. BLOOD BANKS

MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES

List Of Tables

LIST OF TABLES

Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays